IDH2 and glioma: A total of 93 cases of IDH mutant, 1p19q non-codeleted gliomas were evaluated for CDKN2A; 11.8% of cases (11/93) were positive for CDKN2A homozygous deletion, and this was not associated with OS (p = 0.235).